{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:42:45Z","timestamp":1793731365615,"version":"4.6.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Following kidney transplantation, BK virus associated nephropathy (BKVN) occurs in 1 to 10% of kidney transplant recipients (KTR) and represents a major cause of graft loss. We aim at identifying factors associated with biopsy proven BKVN among KTR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective case\u2013control study including all KTR with a biopsy-proven diagnosis of BKVN between 2005 and 2019. Clinical characteristics and outcome were described. For each case, one control KTR without BKV infection was identified and matched by age, transplant date, and donor status. Factors associated with BKVN diagnosis were identified using exact conditional logistic regression. Comparative survival was described using Kaplan\u2013Meier estimator.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Sixty-four cases of BKVN were identified among 1737 new kidney transplantation (3.7% prevalence). Clinical characteristics did not differ between groups, except for a higher c-PRA among cases. BKVN occurred in a median time of 11 (5\u201314.5) months after KT, and was associated with a significantly impaired graft function at diagnosis. Following BKVN, 61 (95%) of the patients had immunosuppression reduction, which led to BKV DNAemia resolution in 49% of cases. In multivariate analysis, factors associated with BKVN diagnosis were lymphopenia\u2009&lt;\u2009500\/mm\n                      <jats:sup>3<\/jats:sup>\n                      and a prednisone dose\u2009&gt;\u20097.5\u00a0mg\/day. Median duration of follow-up was 40\u00a0months for both groups. BKVN was associated with a significantly increased risk of graft rejection (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.02) and return to dialysis (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      BKVN remains a severe complication in KTR and is associated with an increased risk for acute rejection and return to dialysis. Lymphopenia below 500\/mm\n                      <jats:sup>3<\/jats:sup>\n                      and corticosteroid maintenance therapy are significantly associated with biopsy-proven BKVN diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08043-z","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T11:03:58Z","timestamp":1675681438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Characteristics, risk factors and outcome of BKV nephropathy in kidney transplant recipients: a case\u2013control study"],"prefix":"10.1186","volume":"23","author":[{"given":"Julien","family":"Gras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Le Fl\u00e9cher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axelle","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"V\u00e9rine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Amara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Delaugerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Michel","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie No\u00eblle","family":"Peraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"issue":"2","key":"8043_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1128\/CMR.00074-16","volume":"30","author":"GR Ambalathingal","year":"2017","unstructured":"Ambalathingal GR, Francis RS, Smyth MJ, Smith C, Khanna R. BK polyomavirus: clinical aspects, immune regulation, and emerging therapies. Clin Microbiol Rev. 2017;30(2):503\u201328. https:\/\/doi.org\/10.1128\/CMR.00074-16.","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"8043_CR2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S1473-3099(03)00770-9","volume":"3","author":"HH Hirsch","year":"2003","unstructured":"Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis. 2003;3(10):611\u201323.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"8043_CR3","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/TP.0b013e31819cc383","volume":"87","author":"VR Dharnidharka","year":"2009","unstructured":"Dharnidharka VR, Cherikh WS, Abbott KC. An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation. 2009;87(7):1019\u201326. https:\/\/doi.org\/10.1097\/TP.0b013e31819cc383.","journal-title":"Transplantation"},{"issue":"9","key":"8043_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13528","volume":"33","author":"HH Hirsch","year":"2019","unstructured":"Hirsch HH, Randhawa PS, AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9): e13528. https:\/\/doi.org\/10.1111\/ctr.13528.","journal-title":"Clin Transplant"},{"issue":"7","key":"8043_CR5","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/NEJMoa020439","volume":"347","author":"HH Hirsch","year":"2002","unstructured":"Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002;347(7):488\u201396. https:\/\/doi.org\/10.1056\/NEJMoa020439.","journal-title":"N Engl J Med"},{"issue":"5","key":"8043_CR6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/TP.0b013e318197c17d","volume":"87","author":"E Ramos","year":"2009","unstructured":"Ramos E, Drachenberg CB, Wali R, Hirsch HH. The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation. 2009;87(5):621\u201330. https:\/\/doi.org\/10.1097\/TP.0b013e318197c17d.","journal-title":"Transplantation"},{"issue":"3","key":"8043_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3390\/v13030487","volume":"13","author":"CL Shen","year":"2021","unstructured":"Shen CL, Wu BS, Lien TJ, Yang AH, Yang CY. BK polyomavirus nephropathy in kidney transplantation: balancing rejection and infection. Viruses. 2021;13(3):487. https:\/\/doi.org\/10.3390\/v13030487.","journal-title":"Viruses"},{"issue":"9","key":"8043_CR8","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1097\/TP.0b013e3181d0e15e","volume":"89","author":"O Johnston","year":"2010","unstructured":"Johnston O, Jaswal D, Gill JS, Doucette S, Fergusson DA, Knoll GA. Treatment of polyomavirus infection in kidney transplant recipients: a systematic review. Transplantation. 2010;89(9):1057\u201370. https:\/\/doi.org\/10.1097\/TP.0b013e3181d0e15e.","journal-title":"Transplantation"},{"issue":"8","key":"8043_CR9","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/TP.0b013e31826690c6","volume":"94","author":"P Sood","year":"2012","unstructured":"Sood P, Senanayake S, Sujeet K, et al. Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study. Transplantation. 2012;94(8):814\u201321. https:\/\/doi.org\/10.1097\/TP.0b013e31826690c6.","journal-title":"Transplantation"},{"issue":"2","key":"8043_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1600-6143.2009.02952.x","volume":"10","author":"KL Hardinger","year":"2010","unstructured":"Hardinger KL, Koch MJ, Bohl DJ, Storch GA, Brennan DC. BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am J Transplant. 2010;10(2):407\u201315. https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02952.x.","journal-title":"Am J Transplant"},{"issue":"3","key":"8043_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13194","volume":"32","author":"W Cheungpasitporn","year":"2018","unstructured":"Cheungpasitporn W, Kremers WK, Lorenz E, et al. De novo donor-specific antibody following BK nephropathy: the incidence and association with antibody-mediated rejection. Clin Transplant. 2018;32(3): e13194. https:\/\/doi.org\/10.1111\/ctr.13194.","journal-title":"Clin Transplant"},{"issue":"2","key":"8043_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/tid.12051","volume":"15","author":"L Kayler","year":"2013","unstructured":"Kayler L, Zendejas I, Schain D, Magliocca J. Ureteral stent placement and BK viremia in kidney transplant recipients. Transpl Infect Dis. 2013;15(2):202\u20137. https:\/\/doi.org\/10.1111\/tid.12051.","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"8043_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1600-6143.2012.04320.x","volume":"13","author":"HH Hirsch","year":"2013","unstructured":"Hirsch HH, Vincenti F, Friman S, et al. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant. 2013;13(1):136\u201345. https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04320.x.","journal-title":"Am J Transplant"},{"issue":"3","key":"8043_CR14","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.transproceed.2017.01.009","volume":"49","author":"SE Dogan","year":"2017","unstructured":"Dogan SE, Celebi ZK, Akturk S, et al. Prevalence and risk factors of BK viremia in patients with kidney transplantation: a single-center experience from Turkey. Transplant Proc. 2017;49(3):532\u20136. https:\/\/doi.org\/10.1016\/j.transproceed.2017.01.009.","journal-title":"Transplant Proc"},{"issue":"2","key":"8043_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/tri.12888","volume":"30","author":"JG Maliakkal","year":"2017","unstructured":"Maliakkal JG, Brennan DC, Goss C, et al. Ureteral stent placement and immediate graft function are associated with increased risk of BK viremia in the first year after kidney transplantation. Transpl Int. 2017;30(2):153\u201361. https:\/\/doi.org\/10.1111\/tri.12888.","journal-title":"Transpl Int"},{"key":"8043_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/1471-2369-14-207","volume":"14","author":"J Jacobi","year":"2013","unstructured":"Jacobi J, Prignitz A, B\u00fcttner M, et al. BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition. BMC Nephrol. 2013;14:207. https:\/\/doi.org\/10.1186\/1471-2369-14-207.","journal-title":"BMC Nephrol"},{"issue":"3","key":"8043_CR17","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1600-6143.2005.00742.x","volume":"5","author":"DC Brennan","year":"2005","unstructured":"Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant. 2005;5(3):582\u201394. https:\/\/doi.org\/10.1111\/j.1600-6143.2005.00742.x.","journal-title":"Am J Transplant"},{"key":"8043_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jcv.2018.10.002","volume":"109","author":"B Demey","year":"2018","unstructured":"Demey B, Tinez C, Fran\u00e7ois C, et al. Risk factors for BK virus viremia and nephropathy after kidney transplantation: a systematic review. J Clin Virol. 2018;109:6\u201312. https:\/\/doi.org\/10.1016\/j.jcv.2018.10.002.","journal-title":"J Clin Virol"},{"issue":"2","key":"8043_CR19","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1681\/ASN.2017050477","volume":"29","author":"V Nickeleit","year":"2018","unstructured":"Nickeleit V, Singh HK, Randhawa P, et al. The Banff Working Group classification of definitive polyomavirus nephropathy: morphologic definitions and clinical correlations. J Am Soc Nephrol. 2018;29(2):680\u201393. https:\/\/doi.org\/10.1681\/ASN.2017050477.","journal-title":"J Am Soc Nephrol"},{"issue":"s4","key":"8043_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/ajt.12110","volume":"13","author":"HH Hirsch","year":"2013","unstructured":"Hirsch HH, Randhawa P, The AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation: BK polyomavirus in solid organ transplantation. Am J Transplant. 2013;13(s4):179\u201388. https:\/\/doi.org\/10.1111\/ajt.12110.","journal-title":"Am J Transplant"},{"issue":"6","key":"8043_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.5527\/wjn.v5.i6.497","volume":"5","author":"CY Hsiao","year":"2016","unstructured":"Hsiao CY, Pilmore HL, Zhou L, de Zoysa JR. Outcomes of renal transplant recipients with BK virus infection and BK virus surveillance in the Auckland region from 2006 to 2012. World J Nephrol. 2016;5(6):497\u2013506. https:\/\/doi.org\/10.5527\/wjn.v5.i6.497.","journal-title":"World J Nephrol"},{"issue":"1","key":"8043_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1600-6143.2012.04314.x","volume":"13","author":"N Theodoropoulos","year":"2013","unstructured":"Theodoropoulos N, Wang E, Penugonda S, et al. BK virus replication and nephropathy after alemtuzumab-induced kidney transplantation. Am J Transplant. 2013;13(1):197\u2013206. https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04314.x.","journal-title":"Am J Transplant"},{"issue":"7","key":"8043_CR23","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/cid\/ciac071","volume":"75","author":"H Imlay","year":"2022","unstructured":"Imlay H, Baum P, Brennan DC, et al. Consensus definitions of BK polyomavirus nephropathy in renal transplant recipients for clinical trials. Clin Infect Dis. 2022;75(7):1210\u20136. https:\/\/doi.org\/10.1093\/cid\/ciac071.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"8043_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/TP.0b013e3181aa8d93","volume":"88","author":"W Manitpisitkul","year":"2009","unstructured":"Manitpisitkul W, Drachenberg C, Ramos E, et al. Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study. Transplantation. 2009;88(1):83\u20138. https:\/\/doi.org\/10.1097\/TP.0b013e3181aa8d93.","journal-title":"Transplantation"},{"issue":"3","key":"8043_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/01.tp.0000269616.21698.10","volume":"84","author":"A Thomas","year":"2007","unstructured":"Thomas A, Dropulic LK, Rahman MH, Geetha D. Ureteral stents: a novel risk factor for polyomavirus nephropathy. Transplantation. 2007;84(3):433\u20136. https:\/\/doi.org\/10.1097\/01.tp.0000269616.21698.10.","journal-title":"Transplantation"},{"issue":"2","key":"8043_CR26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1399-3062.2006.00167.x","volume":"8","author":"P Comoli","year":"2006","unstructured":"Comoli P, Binggeli S, Ginevri F, Hirsch HH. Polyomavirus-associated nephropathy: update on BK virus-specific immunity. Transpl Infect Dis. 2006;8(2):86\u201394. https:\/\/doi.org\/10.1111\/j.1399-3062.2006.00167.x.","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"8043_CR27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nrneph.2012.64","volume":"8","author":"DRJ Kuypers","year":"2012","unstructured":"Kuypers DRJ. Management of polyomavirus-associated nephropathy in renal transplant recipients. Nat Rev Nephrol. 2012;8(7):390\u2013402. https:\/\/doi.org\/10.1038\/nrneph.2012.64.","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"8043_CR28","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1111\/j.1600-6143.2010.03310.x","volume":"10","author":"S Schaub","year":"2010","unstructured":"Schaub S, Hirsch HH, Dickenmann M, et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy: preservation of allograft function in BKV-infection. Am J Transplant. 2010;10(12):2615\u201323. https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03310.x.","journal-title":"Am J Transplant"},{"issue":"8","key":"8043_CR29","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.2215\/CJN.13221216","volume":"12","author":"SG Mallat","year":"2017","unstructured":"Mallat SG, Tanios BY, Itani HS, et al. CMV and BKPyV infections in renal transplant recipients receiving an mTOR inhibitor-based regimen versus a CNI-based regimen: a systematic review and meta-analysis of randomized, controlled trials. Clin J Am Soc Nephrol. 2017;12(8):1321\u201336. https:\/\/doi.org\/10.2215\/CJN.13221216.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"8043_CR30","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/TP.0b013e31828423cd","volume":"95","author":"RJ Knight","year":"2013","unstructured":"Knight RJ, Gaber LW, Patel SJ, DeVos JM, Moore LW, Gaber AO. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis. Transplantation. 2013;95(7):949\u201354. https:\/\/doi.org\/10.1097\/TP.0b013e31828423cd.","journal-title":"Transplantation"},{"issue":"4","key":"8043_CR31","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/TP.0b013e31817c6447","volume":"86","author":"D Dadhania","year":"2008","unstructured":"Dadhania D, Snopkowski C, Ding R, et al. Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication. Transplantation. 2008;86(4):521\u20138. https:\/\/doi.org\/10.1097\/TP.0b013e31817c6447.","journal-title":"Transplantation"},{"issue":"3","key":"8043_CR32","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/ndt\/gfn671","volume":"24","author":"O Prince","year":"2009","unstructured":"Prince O, Savic S, Dickenmann M, Steiger J, Bubendorf L, Mihatsch MJ. Risk factors for polyoma virus nephropathy. Nephrol Dial Transplant. 2009;24(3):1024\u201333. https:\/\/doi.org\/10.1093\/ndt\/gfn671.","journal-title":"Nephrol Dial Transplant"},{"key":"8043_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8050594","author":"P Attias","year":"2019","unstructured":"Attias P, Melica G, Boutboul D, et al. Epidemiology, risk factors, and outcomes of opportunistic infections after kidney allograft transplantation in the era of modern immunosuppression: a monocentric cohort study. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8050594.","journal-title":"J Clin Med"},{"issue":"11","key":"8043_CR34","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1111\/j.1600-6143.2011.03693.x","volume":"11","author":"T Schachtner","year":"2011","unstructured":"Schachtner T, M\u00fcller K, Stein M, et al. BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy: BKV-specific immunity kinetics. Am J Transplant. 2011;11(11):2443\u201352. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03693.x.","journal-title":"Am J Transplant"},{"issue":"6","key":"8043_CR35","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1097\/TP.0000000000001314","volume":"101","author":"JM Schaenman","year":"2017","unstructured":"Schaenman JM, Korin Y, Sidwell T, et al. Increased frequency of BK virus-specific polyfunctional CD8+ T cells predict successful control of BK viremia after kidney transplantation. Transplantation. 2017;101(6):1479\u201387. https:\/\/doi.org\/10.1097\/TP.0000000000001314.","journal-title":"Transplantation"},{"issue":"8","key":"8043_CR36","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1111\/ajt.13252","volume":"15","author":"T Schachtner","year":"2015","unstructured":"Schachtner T, Stein M, Babel N, Reinke P. The loss of BKV-specific immunity from pretransplantation to posttransplantation identifies kidney transplant recipients at increased risk of BKV replication. Am J Transplant. 2015;15(8):2159\u201369. https:\/\/doi.org\/10.1111\/ajt.13252.","journal-title":"Am J Transplant"},{"issue":"6","key":"8043_CR37","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.transproceed.2019.03.035","volume":"51","author":"O Malik","year":"2019","unstructured":"Malik O, Saleh S, Suleiman B, et al. Prevalence, risk factors, treatment, and overall impact of BK viremia on kidney transplantation. Transplant Proc. 2019;51(6):1801\u20139. https:\/\/doi.org\/10.1016\/j.transproceed.2019.03.035.","journal-title":"Transplant Proc"},{"issue":"4","key":"8043_CR38","doi-asserted-by":"publisher","first-page":"292","DOI":"10.5500\/wjt.v5.i4.292","volume":"5","author":"SM McGregor","year":"2015","unstructured":"McGregor SM, Chon WJ, Kim L, Chang A, Meehan SM. Clinical and pathological features of kidney transplant patients with concurrent polyomavirus nephropathy and rejection-associated endarteritis. World J Transplant. 2015;5(4):292\u20139. https:\/\/doi.org\/10.5500\/wjt.v5.i4.292.","journal-title":"World J Transplant"},{"issue":"8","key":"8043_CR39","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1111\/ajt.14292","volume":"17","author":"BJ Nankivell","year":"2017","unstructured":"Nankivell BJ, Renthawa J, Sharma RN, Kable K, O\u2019Connell PJ, Chapman JR. BK virus nephropathy: histological evolution by sequential pathology. Am J Transplant. 2017;17(8):2065\u201377. https:\/\/doi.org\/10.1111\/ajt.14292.","journal-title":"Am J Transplant"},{"issue":"2","key":"8043_CR40","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/ajt.16189","volume":"21","author":"V Nickeleit","year":"2021","unstructured":"Nickeleit V, Singh HK, Dadhania D, et al. The 2018 Banff Working Group classification of definitive polyomavirus nephropathy: a multicenter validation study in the modern era. Am J Transplant. 2021;21(2):669\u201380. https:\/\/doi.org\/10.1111\/ajt.16189.","journal-title":"Am J Transplant"},{"issue":"7","key":"8043_CR41","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/ndt\/gfy346","volume":"34","author":"N Bischof","year":"2019","unstructured":"Bischof N, Hirsch HH, Wehmeier C, et al. Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes. Nephrol Dial Transplant. 2019;34(7):1240\u201350. https:\/\/doi.org\/10.1093\/ndt\/gfy346.","journal-title":"Nephrol Dial Transplant"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08043-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08043-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08043-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T11:06:12Z","timestamp":1675681572000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08043-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8043"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08043-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,6]]},"assertion":[{"value":"4 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All kidney transplant recipients provided written informed consent at the time of kidney transplantation, for their clinical and biological features to be used for research purpose. The study was approved by the local ethical comity of the Assistance Publique des H\u00f4pitaux de Paris according to the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interest for this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}